Basics Akero Therapeutics, Inc. IPO Date: July 17, 2019 Sector: Healthcare Industry: Biotech Market Cap: $3.31B Activated in VL: True Average Daily Range Avg Daily Range: $0.77 | 2.88% Avg Daily Range (30 D): $1.21 | 3.12% Avg Daily Range (90 D): $1.18 | 2.86% Institutional Daily Volume Avg Daily Volume: .5M Avg Daily Volume (30 D): 1.12M Avg Daily Volume (90 D): 1.15M Trade Size Avg Trade Size (Sh.): 66 Avg Trade Size (Sh.) (30 D): 56 Avg Trade Size (Sh.) (90 D): 60 Institutional Trades Total Inst.Trades: 2,221 Avg Inst. Trade: $2.43M Avg Inst. Trade (30 D): $2.67M Avg Inst. Trade (90 D): $2.69M Avg Inst. Trade Volume: .08M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $3.66M Avg Closing Trade (30 D): $5.08M Avg Closing Trade (90 D): $6.24M Avg Closing Volume: 117.07K         News May 11, 2025 @ 7:21 AM Akero Therapeutics und HistoIndex präsentieren ... Source: N/A May 11, 2025 @ 7:21 AM Akero Therapeutics et HistoIndex présentent de ... Source: N/A May 10, 2025 @ 4:28 PM Akero Therapeutics présente les résultats de... Source: N/A May 10, 2025 @ 4:28 PM Akero Therapeutics präsentiert auf dem EASL-Kon... Source: Akero Therapeutics May 10, 2025 @ 2:28 PM Akero Therapeutics annonce la publication de lââ‚... Source: N/A Financials   TTM Q1 2025 Q4 2024 Basic EPS $-3.75 $-.9 $-.99 Diluted EPS $-3.75 $-.9 $-.99 Revenue $ $ $ Gross Profit $ $ $ Net Income / Loss $ -269.44M $ -70.73M $ -70.02M Operating Income / Loss $ -306.35M $ -80.88M $ -78.03M Cost of Revenue $ $ $ Net Cash Flow $ -437.93M $ -154.32M $ 24.17M PE Ratio